{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:22:14Z","timestamp":1772166134402,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000683","name":"Royal Society of Tropical Medicine and Hygiene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000683","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021573","name":"Muhimbili University of Health and Allied Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021573","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05710-1","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T08:35:43Z","timestamp":1764837343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Barriers and facilitators to the adoption of multiple first-line therapies for management of uncomplicated malaria in Tanzania: a multi-method qualitative study"],"prefix":"10.1186","volume":"25","author":[{"given":"Hafidhi Hussein","family":"Ntissi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabel","family":"Itaeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael Z.","family":"Sangeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George Msema","family":"Bwire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"5710_CR1","unstructured":"AFRIcai. Tanzania Malaria facts. https:\/\/africai.or.tz\/2023\/03\/01\/tanzania-malaria-facts\/. Accessed 18 Nov 2025."},{"key":"5710_CR2","unstructured":"Severe Malaria Observatory. Malaria in Tanzania: Statistics & Facts. https:\/\/www.severemalaria.org\/countries\/tanzania. Accessed 20 Nov 2023."},{"key":"5710_CR3","unstructured":"Ministry of Health (MoH) [Tanzania Mainland], Ministry of Health (MoH) [Zanzibar], National Bureau of Statistics (NBS), Office of the Chief Government Statistician (OCGS), and ICFMinistry of Health (MoH) [Tanzania Mainland], Ministry of Health (MoH) [Zanz and I. Tanzania Demographic and Health Survey and Malaria Indicator Survey 2022 Key Indicators Report. 2023. Pp. 1\u201323."},{"key":"5710_CR4","first-page":"195","volume":"8","author":"J Mo\u00efse","year":"2023","unstructured":"Mo\u00efse J, Kabor T, Siribi M, Hien D, Soulama I, Barry N, et al. Feasibility and acceptability of a strategy deploying multiple first-line artemisinin-based combination therapies for uncomplicated malaria in the health district of Kaya. Burkina Faso Trop Med Infect Dis. 2023;8:195.","journal-title":"Burkina Faso Trop Med Infect Dis"},{"key":"5710_CR5","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S1473-3099(24)00362-1","volume":"24","author":"DS Ishengoma","year":"2024","unstructured":"Ishengoma DS, Mandara CI, Bakari C, Fola AA, Madebe RA, Seth MD, et al. Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance. Lancet Infect Dis. 2024;24:1225\u201333.","journal-title":"Lancet Infect Dis"},{"key":"5710_CR6","first-page":"102","volume-title":"Strategy to respond to antimalarial drug resistance in Africa","author":"WHO","year":"2022","unstructured":"WHO. Strategy to respond to antimalarial drug resistance in Africa. Geneva: World Health Organization; 2022. p. 102."},{"key":"5710_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-022-04180-z","volume":"21","author":"JMT Kabor\u00e9","year":"2022","unstructured":"Kabor\u00e9 JMT, Siribi\u00e9 M, Hien D, Soulama I, Barry N, Nombr\u00e9 Y, et al. Attitudes, practices, and determinants of community care-seeking behaviours for fever\/malaria episodes in the context of the implementation of multiple first-line therapies for uncomplicated malaria in the health district of Kaya, Burkina Faso. Malar J. 2022;21:155.","journal-title":"Malar J"},{"key":"5710_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001984","volume":"13","author":"MF Boni","year":"2016","unstructured":"Boni MF, White NJ, Baird JK. The community as the patient in malaria-endemic areas: preempting drug resistance with multiple first-line therapies. PLoS Med. 2016;13:e1001984.","journal-title":"PLoS Med"},{"key":"5710_CR9","doi-asserted-by":"publisher","first-page":"14216","DOI":"10.1073\/pnas.0804628105","volume":"105","author":"MF Boni","year":"2008","unstructured":"Boni MF, Smith DL, Laxminarayan R. Benefits of using multiple first-line therapies against malaria. Proc Natl Acad Sci USA. 2008;105:14216\u201321.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5710_CR10","unstructured":"WHO. Global technical strategy for malaria, 2016\u20132030. Global Malaria Programme, World Health Organization; 2015. 29 p. https:\/\/www.who.int\/docs\/default-source\/documents\/global-technical-strategy-for-malaria-2016-2030.pdf#:~:text=Adopted%20by%20the%20World%20Health%20Assembly%20in%20May%202015,%20the. Accessed 7 Oct 2024."},{"key":"5710_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12936-025-05580-7","volume":"24","author":"A Cole","year":"2025","unstructured":"Cole A, Chege T, Aman R, Githuka G, Muga R, Aspinall A, et al. Health system challenges and facilitators associated with adaptive cycling deployment of multiple first-line treatment for uncomplicated malaria: a pilot study in a malaria-endemic region of Kenya. Malar J. 2025;24:328.","journal-title":"Malar J"},{"key":"5710_CR12","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala B, Fukuda N, Ikeda M, Katuro OT, Tachibana SI, Yamauchi M, et al. Evidence of artemisinin-resistant malaria in Africa. N Engl J Med. 2021;385:1163\u201371.","journal-title":"N Engl J Med"},{"key":"5710_CR13","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","volume":"26","author":"A Uwimana","year":"2020","unstructured":"Uwimana A, Legrand E, Stokes BH, Ndikumana JLM, Warsame M, Umulisa N, et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat Med. 2020;26:1602\u20138.","journal-title":"Nat Med"},{"key":"5710_CR14","unstructured":"WHO. Multiple first-line therapies as part of the response to antimalarial drug resistance . Geneva: World Health Organization. 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240103603?utm. Accessed 23 Aug 2025."},{"key":"5710_CR15","unstructured":"Tanzania National Malaria Control Programme. Malaria diagnosis, treatment and preventive therapies guideline 2020. https:\/\/www.nmcp.go.tz\/publication. Accessed 28 Jan 2024."},{"key":"5710_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77\u2013101.","journal-title":"Qual Res Psychol"},{"key":"5710_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1177\/1094428115610808","volume":"20","author":"SF Turner","year":"2017","unstructured":"Turner SF, Cardinal LB, Burton RM. Research design for mixed methods: a triangulation-based framework and roadmap. Organ Res Methods. 2017;20:243\u201367.","journal-title":"Organ Res Methods"},{"key":"5710_CR18","unstructured":"The United Republic of Tanzania Ministry of Health, Community Development, Gender, Elderly and Children. National malaria strategic plan 2021\u20132025 transitioning to malaria elimination in phases. National malaria control programme. 2020."},{"key":"5710_CR19","volume":"6","author":"O Ezezika","year":"2022","unstructured":"Ezezika O, El-Bakri Y, Nadarajah A, Barrett K. Implementation of insecticide-treated malaria bed nets in Tanzania: a systematic review. J Glob Health Rep. 2022;6:e2022036.","journal-title":"J Glob Health Rep"},{"key":"5710_CR20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12936-025-05417-3","volume":"24","author":"K Taremwa","year":"2025","unstructured":"Taremwa K, Anyamene EL, Nwankwo GI, Agbontale MK, Isiko I. Barriers to effective usage of insecticide-treated mosquito nets (ITNS) among women of reproductive age in Tanzania: a national cross-sectional survey. Malar J. 2025;24:234.","journal-title":"Malar J"},{"key":"5710_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-025-05493-5","volume":"24","author":"RM Guissou","year":"2025","unstructured":"Guissou RM, Kabor\u00e9 JMT, Soulama I, Hien D, Nombr\u00e9 Y, Tiono AB, et al. Multiple first-line therapeutic strategies to mitigate artemisinin resistance: cost analysis of a pilot study from a health system perspective in Kaya health district, Burkina Faso. Malar J. 2025;24:254.","journal-title":"Malar J"},{"key":"5710_CR22","unstructured":"Shretta R. Operational challenges of implementing multiple first-line therapies for malaria in endemic countries operational challenges of implementing multiple first-line therapies for malaria in endemic countries. Management Sciences for Health. 2008. https:\/\/onehealthtrust.org\/wp-content\/uploads\/2017\/06\/shretta.2008.operationalchallengesofimplementingmultiplefirstlinetherapies_5.pdf."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05710-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05710-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05710-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:02:14Z","timestamp":1767974534000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12936-025-05710-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5710"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05710-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7711744\/v1","asserted-by":"object"}]},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As the study involved human participants, ethical approval was obtained from the Institutional Ethical Review Board of the Muhimbili University of Health and Allied Sciences (MUHAS) (Ref: MUHAS-REC-03-2025-2739). Additionally, official permission was obtained to conduct interviews with personnel from the National Malaria Control Programme (NMCP), Medical Stores Department (MSD), President's Office\u2014Regional Administration and Local Government (PO-RALG), and selected health facilities, in accordance with institutional requirements. The study was conducted in compliance with the Declaration of Helsinki on research involving human subjects, ensuring respect for participants' rights, protection of welfare, and maintenance of confidentiality. Informed consent was obtained electronically prior to participation. Participants were provided with detailed information about the study's purpose, procedures, potential risks, and benefits via email and Zoom briefing. Consent was documented verbally at the start of each recorded Zoom session. Participation was voluntary, and participants were reminded of their right to withdraw at any time without penalty or consequence. Confidentiality and anonymity were assured throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}